1) Head and neck cancer
头颈部癌
1.
Reduction of postradiation xerostomia in patients with head and neck cancer by superior technology using 3D-RTPS;
三维放疗计划优化技术减少头颈部癌放射性口干症
2.
The rate of xerostomia is high in patients with head and neck cancer after conventional radiation therapy.
我们在2001年对20例头颈部癌放疗患者分成常规放疗组和3DCRT组行放射治疗,常规放疗组肿瘤剂量55。
3.
Objective:to evaluate the feasibility and the short-and medium-term clinical effects of ~(125)I implantation in recurrent or metastatic Head and Neck cancer.
方法:2003年1月～2008年5月对35例(男23例,女12例,年龄39～71岁,中位年龄为56岁)头颈部癌术后或放化疗后复发或转移,在局部浸润麻醉下,CT、B超或腔内镜引导125I粒子植入术,可评价病灶42个,病灶最大径2。
2) head and neck squamous cell carcinoma
头颈部鳞癌
1.
Cetuximab plus other methods in the treatment of patients with head and neck squamous cell carcinomas(HNSCC);
西妥昔单抗联合其他治疗方法治疗头颈部鳞癌
2.
Study on the gene abnormalities of p53-mdm2 in head and neck squamous cell carcinoma;
头颈部鳞癌中p53-mdm2基因异常的研究
3.
The recent situation of study on the tumor suppressor gene FHIT in head and neck squamous cell carcinoma (A review);
FHIT抑癌基因在头颈部鳞癌中的研究进展(综述)
3) Head and neck squamous cell carcinoma
头颈部鳞状细胞癌
1.
Expression of fragile histidine traid in head and neck squamous cell carcinoma and relation with metastasis;
头颈部鳞状细胞癌组织中脆性组氨酸三联体基因的表达
2.
Background: Head and neck squamous cell carcinoma(HNSCC)is the sixth most common cancer worldwide.
研究背景: 头颈部鳞状细胞癌(Head and Neck Squamous Cell Carcinoma,HNSCC)是全球人类第六高发癌,目前主要治疗手段是手术,结合辅助性放疗和化疗。
4) Recurrent advanced head and neck cancer
复发性晚期头颈部癌
5) Head and neck cancer
头颈癌
1.
Pedicled pectoralis major muscle flap surgery in the head and neck cancer after radiotherapy;
带蒂胸大肌肌皮瓣移植在头颈癌放疗后手术中的运用
2.
The application of electroporation therapy in the treatment of head and neck cancer;
电穿孔疗法在头颈癌治疗中的应用
3.
Objective: To determine the chemo-sensitivity of head and neck cancer cells after transfected with mutant Nbs1(Nijmegen breakage syndrome 1) gene.
目的:探讨突变型Nbs1基因转染对头颈癌细胞化疗敏感性的影响。
补充资料：阴蒂部外阴癌
阴蒂部外阴癌
此癌系外阴癌病灶发生在阴蒂部位。其特点在于淋巴转移可以不经浅腹股沟淋巴结而至深腹股沟淋巴结，可经耻骨联合上下方直达盆腔淋巴结。其分期、预后及治疗同外阴癌。但手术时应考虑同时作双侧盆腔淋巴切除术。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条